The GMP testing service market is expected to register a CAGR of 6.5% during the forecast period due to the growing pharmaceutical industry and the increasing need for developing novel devices and drugs. According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of the pharmaceutical industry worldwide were recorded to be approximately USD 852,647 million in 2017. Furthermore, according to the International Journal of Environmental Research and Public Health’s published study, around 40 medications are recalled per year in the United States and South Korea. This emerges the need for testing the products and the manufacturing process. Furthermore, outsourcing these services enables companies to reduce capital investments. Hence, these factors are expected to play a major role in the GMP testing services market growth. However, the precise requirement of the regulatory framework concerning GMP outsourced activities may hinder the market growth.
Key Market Trends Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Hold a Major Market Share in the GMP Testing Service Market
- The novel drug development in the pharmaceutical and biopharmaceutical industry is expected to drive the market growth in this segment. According to the study published by the Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decades. The economic output of the biopharmaceutical industry was accounted to be USD 1.3 trillion in 2015, according to the International Trade Administration. This demands more quality and safety management of products, which is expected to increase GMP testing services. - Moreover, according to the US FDA (Food & Drug Administration) list of GMP facilities, there are around 3,652 facilities related to packaging, analytical testing in 36 countries. Approximately 2,515 facilities in the list accounted for API production facilities and finished dosage form facilities. Thus, the pharmaceutical and biopharmaceutical companies segment is expected to positively impact the GMP testing services market growth.
North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period.
North America is expected to be a dominant region in the GMP testing services market due to the emerging need for developing new drugs and devices. According to the Centre for Disease Control and Prevention, around USD 3.5 trillion of the amount is spent on chronic diseases in the United States. According to the same source, around 859,000 people die due to heart stroke in the United States. The number of increasing drug manufacturing plants is expected to drive the GMP testing services market growth. According to the United States Food & Drug Administration (FDA), the United States had approximately 4,676 manufacturing sites for drugs. Hence, these factors demand developing new drugs and are expected to boost the demand for GMP testing services market growth.
Competitive Landscape The GMP testing service market consists of several major players. In terms of market share, few of the major players are currently dominating the market. Furthermore, the companies are taking initiatives to meet the higher demand for medicines and devices. For instance, PPD, Inc., in 2018, set up a new plant facility dedicated to the testing of biologics. Some of the companies which are currently dominating the market are Eurofins Scientific, PPD, Inc., Microchem Laboratory, Sartorius AG, North American Science Associates Inc., Covance, Inc., Nelson Laboratories, LLC, Almac Group, Pace Analytical, and Wuxi AppTec.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - 3 months of analyst support
Our reports have been used by over 10K customers, including:
The electronic nose market was valued at USD 17.9 million in 2020, and it is expected to reach a market value of USD 34.2 million by 2026, to register a CAGR of 11.8% over the forecast period (2021 - 2026). The demand for electronic nose technology has been positively impacted by the wave of disruptive technological advances, such as cloud,...
The global macular degeneration treatment market was valued at USD 7,755 million in 2020, and it is expected to reach USD 11,492 million by 2026, registering a CAGR of 6.9% during the period of 2021-2026. The COVID-19 pandemic had a potential economic impact and implications on most of the sectors, including the pharmaceutical and biotech...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The Vascular Embolization market was valued at approximately USD 1,381.20 million in 2020 and is expected to witness a revenue of USD 2,375.14 million in 2026, with a CAGR of 9.50% over the forecast period. The outbreak of COVID-19 impacted the vascular embolization market, as hospitals and healthcare services for non-covid indications...
292 pages •
By The Business Research Company
• Mar 2021
Ultrasound Devices And Equipment Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global ultrasound devices and equipment market as it emerges from the COVID 19 shut down. Description: Where...
The growing preference for minimally-invasive surgeries, increasing adoption of endoscopes for treatment and diagnosis, and technological advancements leading to enhanced applications are the major factors leading to the growth of the market studied. However, the lack of skilled technicians and infections caused by few endoscopes is hindering...
Anesthesia is one of the most essential components for any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017, with...
The stem cell market was valued at USD 14.7 billion in 2020, and it is expected to reach approximately USD 26.40 billion in 2026, registering a CAGR of nearly 10.24% during the forecast period, 2021-2026. The growth of the market is attributed to the rising number of clinical trials and the growing adoption of stem cell therapies globally....
274 pages •
By Asia Market Information & Development Company
• Jun 2021
China’s demand for Blood Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
The Viral Vector Manufacturing Market was estimated to be USD 601.36 million in 2020 and is poised to grow at a CAGR of 27.36% by 2026 to reach USD 2,579.85 million. The COVID-19 pandemic has underlined the importance of vaccine development for the global population. According to the World Health Organisation (WHO), around 151 vaccine...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.